{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T08:55:05Z","timestamp":1792313705125,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10067-025-07521-w","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:16:49Z","timestamp":1750965409000},"page":"3341-3352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term clinical prognosis of anti-aminoacyl-tRNA synthetase antibodies and interstitial lung disease"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8428-2046","authenticated-orcid":false,"given":"Koichi","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5277-521X","authenticated-orcid":false,"given":"Daniel I.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7346-7141","authenticated-orcid":false,"given":"Singh","family":"Khushboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-597X","authenticated-orcid":false,"given":"Didem","family":"Saygin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Martinez","family":"Laverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0994-1590","authenticated-orcid":false,"given":"Siamak","family":"Moghadam-Kia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1387-0860","authenticated-orcid":false,"given":"Dana P.","family":"Ascherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9529-3111","authenticated-orcid":false,"given":"Chester V.","family":"Oddis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7531-8038","authenticated-orcid":false,"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"7521_CR1","doi-asserted-by":"crossref","unstructured":"Ernste FC, Reed AM (2013) Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations Mayo Clinic Proceedings Elsevier, pp 83\u2013105","DOI":"10.1016\/j.mayocp.2012.10.017"},{"key":"7521_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","volume":"19","author":"T Khoo","year":"2023","unstructured":"Khoo T, Lilleker JB, Thong BY-H, Leclair V, Lamb JA, Chinoy H (2023) Epidemiology of the idiopathic inflammatory myopathies. Nat Rev Rheumatol 19:695\u2013712","journal-title":"Nat Rev Rheumatol"},{"key":"7521_CR3","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00296-017-3799-x","volume":"37","author":"L Nu\u00f1o-Nu\u00f1o","year":"2017","unstructured":"Nu\u00f1o-Nu\u00f1o L, Joven BE, Carreira PE et al (2017) Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain. Rheumatol Int 37:1853\u20131861","journal-title":"Rheumatol Int"},{"key":"7521_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11926-012-0249-3","volume":"14","author":"I Marie","year":"2012","unstructured":"Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14:275\u2013285","journal-title":"Curr Rheumatol Rep"},{"key":"7521_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.55563\/clinexprheumatol\/brvl1v","volume":"40","author":"RW Hallowell","year":"2021","unstructured":"Hallowell RW, Paik JJ (2021) Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management. Clin Exp Rheumatol 40:373","journal-title":"Clin Exp Rheumatol"},{"key":"7521_CR6","first-page":"692","volume":"16","author":"GJ Hengstman","year":"2004","unstructured":"Hengstman GJ, van Engelen BG, van Venrooij WJ (2004) Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol 16:692\u2013699","journal-title":"Curr Opin Rheumatol"},{"key":"7521_CR7","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/S2665-9913(23)00322-3","volume":"6","author":"CM Connolly","year":"2024","unstructured":"Connolly CM, Gupta L, Fujimoto M, Machado PM, Paik JJ (2024) Idiopathic inflammatory myopathies: current insights and future frontiers. The Lancet Rheumatol 6:e115\u2013e127","journal-title":"The Lancet Rheumatol"},{"key":"7521_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/2397198320902667","volume":"5","author":"K Huang","year":"2020","unstructured":"Huang K, Aggarwal R (2020) Antisynthetase syndrome: a distinct disease spectrum. J Scleroderma Related Disord 5:178\u2013191","journal-title":"J Scleroderma Related Disord"},{"key":"7521_CR9","doi-asserted-by":"publisher","first-page":"e60442","DOI":"10.1371\/journal.pone.0060442","volume":"8","author":"Y Hamaguchi","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T et al (2013) Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS ONE 8:e60442","journal-title":"PLoS ONE"},{"key":"7521_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-021-01399-5","volume":"21","author":"X Zhan","year":"2021","unstructured":"Zhan X, Yan W, Wang Y et al (2021) Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. BMC Pulm Med 21:1\u20139","journal-title":"BMC Pulm Med"},{"key":"7521_CR11","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.rmed.2011.03.022","volume":"105","author":"K Watanabe","year":"2011","unstructured":"Watanabe K, Handa T, Tanizawa K et al (2011) Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med 105:1238\u20131247","journal-title":"Respir Med"},{"key":"7521_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.rmed.2017.04.007","volume":"127","author":"K Tanizawa","year":"2017","unstructured":"Tanizawa K, Handa T, Nakashima R et al (2017) The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies. Respir Med 127:57\u201364","journal-title":"Respir Med"},{"key":"7521_CR13","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s10067-015-3023-x","volume":"34","author":"J Rojas-Serrano","year":"2015","unstructured":"Rojas-Serrano J, Herrera-Bringas D, Mej\u00eda M, Rivero H, Mateos-Toledo H, Figueroa JE (2015) Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD). Clin Rheumatol 34:1563\u20131569","journal-title":"Clin Rheumatol"},{"key":"7521_CR14","doi-asserted-by":"publisher","first-page":"872615","DOI":"10.3389\/fimmu.2022.872615","volume":"13","author":"N Zhao","year":"2022","unstructured":"Zhao N, Jiang W, Wu H et al (2022) Clinical features, prognostic factors, and survival of patients with antisynthetase syndrome and interstitial lung disease. Front Immunol 13:872615","journal-title":"Front Immunol"},{"key":"7521_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","volume":"56","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA et al (2017) A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. Rheumatology 56:999\u20131007","journal-title":"Rheumatology"},{"key":"7521_CR16","doi-asserted-by":"publisher","first-page":"106432","DOI":"10.1016\/j.rmed.2021.106432","volume":"191","author":"EM Wilfong","year":"2022","unstructured":"Wilfong EM, Young-Glazer JJ, Sohn BK et al (2022) Anti-tRNA synthetase syndrome interstitial lung disease: a single center experience. Respir Med 191:106432","journal-title":"Respir Med"},{"key":"7521_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"7521_CR18","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725\u20131725","journal-title":"Arthritis Rheum"},{"key":"7521_CR19","doi-asserted-by":"crossref","unstructured":"Masi AT, Diagnostic SFSCotARA, Committee TC (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581-590","DOI":"10.1002\/art.1780230510"},{"key":"7521_CR20","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative. Arthritis Rheum 65:2737","journal-title":"Arthritis Rheum"},{"key":"7521_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum: Official J Am College Rheumatol 31:315\u2013324","journal-title":"Arthritis Rheum: Official J Am College Rheumatol"},{"key":"7521_CR22","unstructured":"Sharp GC (1987) Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC (eds) Mixed Connective Tissue Disease and Antinuclear Autoantibodies. Elsevier, Amsterdam, pp 23\u201332"},{"key":"7521_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10067-014-2730-z","volume":"33","author":"LA Aguila","year":"2014","unstructured":"Aguila LA, Lopes MRU, Pretti FZ et al (2014) Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis. Clin Rheumatol 33:1093\u20131098","journal-title":"Clin Rheumatol"},{"key":"7521_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"key":"7521_CR25","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL et al (2018) Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 198:e44\u2013e68","journal-title":"Am J Respir Crit Care Med"},{"key":"7521_CR26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"Society ER, Society AT","year":"2002","unstructured":"Society ER, Society AT (2002) American thoracic society. Am J Respir Crit Care Med 165:277\u2013304","journal-title":"Am J Respir Crit Care Med"},{"key":"7521_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.rmed.2016.07.009","volume":"118","author":"AC Zamora","year":"2016","unstructured":"Zamora AC, Hoskote SS, Abascal-Bolado B et al (2016) Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome. Respir Med 118:39\u201345","journal-title":"Respir Med"},{"key":"7521_CR28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/rheumatology\/kew396","volume":"56","author":"R Aggarwal","year":"2017","unstructured":"Aggarwal R, McBurney C, Schneider F et al (2017) Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis. Rheumatology 56:384\u2013389","journal-title":"Rheumatology"},{"key":"7521_CR29","doi-asserted-by":"publisher","first-page":"e98824","DOI":"10.1371\/journal.pone.0098824","volume":"9","author":"T Fujisawa","year":"2014","unstructured":"Fujisawa T, Hozumi H, Kono M et al (2014) Prognostic factors for myositis-associated interstitial lung disease. PLoS ONE 9:e98824","journal-title":"PLoS ONE"},{"key":"7521_CR30","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00296-016-3571-7","volume":"36","author":"J Obert","year":"2016","unstructured":"Obert J, Freynet O, Nunes H et al (2016) Outcome and prognostic factors in a French cohort of patients with myositis-associated interstitial lung disease. Rheumatol Int 36:1727\u20131735","journal-title":"Rheumatol Int"},{"key":"7521_CR31","doi-asserted-by":"publisher","first-page":"e85062","DOI":"10.1371\/journal.pone.0085062","volume":"9","author":"R Nakashima","year":"2014","unstructured":"Nakashima R, Imura Y, Hosono Y et al (2014) The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia. PLoS ONE 9:e85062","journal-title":"PLoS ONE"},{"key":"7521_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1183\/16000617.00002015","volume":"24","author":"J-C Lega","year":"2015","unstructured":"Lega J-C, Reynaud Q, Belot A, Fabien N, Durieu I, Cottin V (2015) Idiopathic inflammatory myopathies and the lung. Eur Respir Rev 24:216\u2013238","journal-title":"Eur Respir Rev"},{"key":"7521_CR33","doi-asserted-by":"publisher","first-page":"e0120313","DOI":"10.1371\/journal.pone.0120313","volume":"10","author":"H Hozumi","year":"2015","unstructured":"Hozumi H, Enomoto N, Kono M et al (2015) Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis\/dermatomyositis-associated interstitial lung disease: a retrospective case control study. PLoS ONE 10:e0120313","journal-title":"PLoS ONE"},{"key":"7521_CR34","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","volume":"57","author":"S Sato","year":"2018","unstructured":"Sato S, Masui K, Nishina N et al (2018) Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients. Rheumatology 57:1212\u20131221","journal-title":"Rheumatology"},{"key":"7521_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amjms.2017.07.013","volume":"355","author":"F Chen","year":"2018","unstructured":"Chen F, Li S, Wang T, Shi J, Wang G (2018) Clinical heterogeneity of interstitial lung disease in polymyositis and dermatomyositis patients with or without specific autoantibodies. Am J Med Sci 355:48\u201353","journal-title":"Am J Med Sci"},{"key":"7521_CR36","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3899\/jrheum.161480","volume":"44","author":"J Shi","year":"2017","unstructured":"Shi J, Li S, Yang H et al (2017) Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies. J Rheumatol 44:1051\u20131057","journal-title":"J Rheumatol"},{"key":"7521_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","volume":"83","author":"K Dank\u00f3","year":"2004","unstructured":"Dank\u00f3 K, Ponyi A, Constantin T, Borgulya G, Szegedi G (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine 83:35\u201342","journal-title":"Medicine"},{"key":"7521_CR38","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/1756-185X.14128","volume":"24","author":"Z Bai","year":"2021","unstructured":"Bai Z, Shen G, Dong L (2021) Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy. Int J Rheum Dis 24:815\u2013827","journal-title":"Int J Rheum Dis"},{"key":"7521_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","volume":"80","author":"A-M Hoffmann-Vold","year":"2021","unstructured":"Hoffmann-Vold A-M, Allanore Y, Alves M et al (2021) Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Ann Rheum Dis 80:219\u2013227","journal-title":"Ann Rheum Dis"},{"key":"7521_CR40","doi-asserted-by":"crossref","unstructured":"Zhang XJ, Bonner A, Hudson M, Baron M, Pope J, Group CSR (2013) Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis. J Rheumatol 40: 850-858","DOI":"10.3899\/jrheum.120705"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07521-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07521-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07521-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:45:57Z","timestamp":1757198757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07521-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7521"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07521-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"23 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"This research received no specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}